Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.

Status:
Recruiting

Trial end date:
2025-07-30

Target enrollment:

Participant gender:

The primary objective of the trial is to assess long-term safety and tolerability of apraglutide in subjects with SBS-IF.

Phase 3

VectivBio AG